StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sinovac Biotech's price to book ratio was 0.1× on Nov 11, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.1× to 0.9×, with a median of 0.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×+0.0
2025Dec 31, 20250.1×+0.0
2024Dec 31, 20240.1×+0.0
2023Dec 29, 20230.1×+0.0
2022Dec 30, 20220.1×−0.8
2021Dec 31, 20210.9×−1.3
2020Dec 31, 20202.2×+0.4
2019Dec 31, 20191.8×−0.8
2018Dec 31, 20182.6×−1.3
2017Dec 29, 20173.9×+1.1
2016Dec 30, 20162.8×+0.2
2015Dec 31, 20152.5×+0.3
2014Dec 31, 20142.3×−0.6
2013Dec 31, 20132.9×+1.5
2012Dec 31, 20121.3×+0.4
2011Dec 30, 20110.9×–

More Sinovac Biotech figures

See a number that looks wrong?